SX-ARPC

N/A

Report date: 2025/06/11 10:49:41
NME

Base Information

Drug NameSX-ARPC
Drug Alias Nameandrogen receptor antagonists (Serometrix)ADR-L09SX-ARPC
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionAndrogen Receptor degraders
TargetsAndrogen Receptor
Therapy Area/IndicationsHormone-Resistant Prostate Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSerometrix LLC
China Registration ClassN/A

Develop Information

Active CompaniesSerometrix LLC
Inactive CompaniesN/A
Active IndicationsHormone-Resistant Prostate Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A